SCHEMBL16975185

SCHEMBL16975185

CCCCOC(=O)NC(CCC(CO)C(=O)OCC)c1ccc(-c2cccc(F)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 1/20 0.49
▸ FAAH O00519 7/20 0.44
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ACACB O00763 3/20 0.39
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ ACACA Q13085 2/20 0.38
▸ MMEL1 Q495T6 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ GPR88 Q9GZN0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16975187 0.90 MMEL1 (0.45) MMEFAAHMAPK1SMN1; SMN2ACACB
SCHEMBL12481768 0.80 MME (0.49) MMEFAAHACACBMMP2MMP3
SCHEMBL2707583 0.79 MMEL1 (0.47) MMEMAPK1SMN1; SMN2ACACBACACA
SCHEMBL2877470 0.76 MMEL1 (0.59) FAAHSMN1; SMN2ACACBACACAMMEL1
SCHEMBL8932530 0.76 FAAH (0.51) FAAHMAPK1SMN1; SMN2ROCK2ROCK1
SCHEMBL12684793 0.75 MME (0.60) MMEMMP2MMP3MMEL1
SCHEMBL2873143 0.75 MMEL1 (0.57) FAAHSMN1; SMN2ACACBACACAMMEL1
SCHEMBL12481143 0.74 MMP2 (0.51) MMEMMP2MMP3MMEL1
SCHEMBL15564105 0.74 MMEL1 (0.42) MMEFAAHMAPK1SMN1; SMN2MMEL1
SCHEMBL16975135 0.73 MME (0.45) MMEFAAHMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099678-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-12-07 — — EP disclosed
WO-2015116786-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-06 — — WO disclosed
Send feedback